Starget Pharma
Sector: Healthcare & Life Sciences
About Starget Pharma
Starget Skip to content Home Technology Pipeline Leadership News Home Technology Pipeline Leadership News New Hope for Cancer Patients Starget Pharma is a clinical company developing a new class of Smart Targeted Radioligands (STRs) for precision oncology of hard-to-heal cancers. Our AI-driven peptide-based discovery engine enables the rapid identification of radioligands that deliver high-energy
Products
Starget
Designs Smart Targeted Radioligands (STRs)—AI-optimized molecules that bind to tumor-specific targets and deliver cytotoxic radiation. These radioligands exploit biological differences between tumor and normal tissue to maximize treatment precision. By leveraging peptide dynamics and AI, we optimize affinity, chelation stability, and biodistribution—key properties for effective and tolerable cancer treatment.